SCHEMBL4499008

SCHEMBL4499008

CCOc1ccc(C(=O)OCc2cccc(CC(OC(C)C)C(=O)O)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
TP53 P04637 1/20 0.48
PKM P14618 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
MRGPRX4 Q96LA9 1/20 0.48
KMT2A Q03164 2/20 0.45
GAA P10253 2/20 0.44
PPARA Q07869 7/20 0.44
PPARD Q03181 4/20 0.44
RAB9A P51151 4/20 0.43
PTPRC P08575 1/20 0.43
PTPN1 P18031 1/20 0.43
NPC1 O15118 3/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4328008 0.85 TP53 (0.47) PPARGSMN1; SMN2TP53PKMNFKB1
SCHEMBL4499011 0.83 GAA (0.46) PPARGSMN1; SMN2PKMKMT2AGAA
SCHEMBL4327970 0.82 MAPT (0.46) PPARGKMT2APPARAPPARDRAB9A
SCHEMBL4327964 0.82 MAPT (0.46) PPARGKMT2APPARAPPARDRAB9A
SCHEMBL4339204 0.80 MGLL (0.47) PPARGSMN1; SMN2TP53KMT2APPARA
SCHEMBL13819711 0.79 PPARG (0.57) PPARGPPARAPPARD
SCHEMBL4347157 0.79 PPARA (0.61) PPARGPPARAPPARD
SCHEMBL20830918 0.77 KMT2A (0.67) SMN1; SMN2TP53PKMNFKB1NFKB2
SCHEMBL13819766 0.77 PPARA (0.58) PPARGMRGPRX4PPARAPPARDPTPRC
SCHEMBL13819475 0.76 MRGPRX4 (0.59) PPARGMRGPRX4PPARAPPARDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 PPARG 379/4885SMN1; SMN2 3054/4885TP53 4574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.